To apply for Class D medical device registration under Hong Kong’s Medical Device Administrative Control System (MDACS), you must satisfy a series of regulatory, technical, and administrative conditions. Class D is the highest-risk class, so the Hong Kong Department of Health (DoH) applies strict eligibility criteria.
Below is a detailed list of the conditions that must be met before you can submit an MDACS registration for a Class D medical device:
Devices that sustain or support life
Devices used in life-threatening situations
Devices that are implantable (e.g., pacemakers, artificial heart valves)
In vitro diagnostic (IVD) devices used for:
Screening for high-risk infectious diseases (e.g., HIV, hepatitis)
Blood grouping or compatibility testing
🔎 Use Technical Reference TR-003 (general MDs) or TR-006 (IVDs) to confirm the classification.
If the manufacturer is not based in Hong Kong, you must appoint a Local Responsible Person who is:
A registered business in Hong Kong
Responsible for:
Submitting the registration through MDIS
Post-market surveillance and vigilance reporting
Product traceability and recall management
📌 Only the LRP can submit an MDACS application on behalf of a foreign manufacturer.
The device must already be approved, cleared, or registered in at least one of the following countries/regions:
| Region | Acceptable Approvals |
|---|---|
| European Union | CE Certificate (MDR/IVDR) |
| United States | FDA 510(k), PMA, or De Novo |
| Canada | Health Canada MDL |
| Australia | TGA ARTG inclusion |
| Japan | MHLW/PMDA Shonin approval |
| China | NMPA (formerly CFDA) approval |
| South Korea | MFDS certificate |
| Singapore | HSA registration |
📄 Proof required: Certificate of Free Sale (CFS) or registration/approval certificate
You must hold a valid ISO 13485:2016 Quality Management System certificate that covers:
The entire production and design process
Issued by an accredited and recognized certification body
The scope must match the product type
You must demonstrate conformity to the Essential Principles outlined in:
GN-01 for general medical devices
GN-02 for in vitro diagnostic devices
A Declaration of Conformity must be signed and submitted by the manufacturer.
You must be able to submit or provide the following:
| Required Document | Standard/Format |
|---|---|
| Clinical Evaluation Report (CER) | Based on clinical trials, real-world data, or literature |
| Risk Management File | Per ISO 14971 |
| Device Description | Design, materials, components |
| Labeling and IFU | In English and/or Traditional Chinese |
| Test Reports | Electrical safety (IEC 60601), EMC, sterility, biocompatibility, etc. |
| Post-Market Surveillance Plan | Includes vigilance, recall, complaint handling procedures |
🗂 These documents must be prepared in PDF format and submitted through the MDIS platform.
Even though MDACS is voluntary (as of 2025), it applies only to devices that are:
Distributed, sold, or used in the Hong Kong market
Not solely for re-export purposes
❗ Devices used only in clinical trials or not for local use do not need MDACS registration.
Because Class D devices involve high risk, the Clinical Evaluation Report must demonstrate:
Safety under actual use conditions
Clinical benefit, ideally supported by:
Clinical trials
Literature analysis
Equivalence to approved/predicate devices
🧪 For IVDs: You may need clinical performance data such as sensitivity, specificity, reproducibility, and validation reports.
As part of registration, the LRP must commit to:
Ongoing adverse event reporting
Field safety corrective actions (FSCA) and recalls if necessary
Maintaining traceability of distributed devices in Hong Kong
Submitting updated documents if device design or labeling changes
| Condition | Requirement |
|---|---|
| ✅ Device classification | Must be confirmed as Class D |
| ✅ Local Responsible Person | Must be appointed and registered in HK |
| ✅ Overseas regulatory approval | CE, FDA, TGA, etc. |
| ✅ ISO 13485 QMS | Certificate must be valid and product-specific |
| ✅ Essential principles compliance | Via GN-01 / GN-02 |
| ✅ Technical documentation | Must be complete and current |
| ✅ Clinical evaluation | Valid and relevant data required |
| ✅ PMS system | Must be described and in place |
| ✅ Distribution in Hong Kong | Product must be marketed locally |
| ✅ MDIS submission | Must be done online by LRP |

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn